Evidence map›Paper›PMID 41884791›Full record

ArticleTherapeutic advances in infectious disease

Harm reduction in practice: baseline cohort description and early engagement trends in an incentive-based program for PWUD.

Nadia Mattanah, Aditi Ringwala, Atri Surapaneni, Kellie Miller, Anne Sawyer, Shivakumar Narayanan

Abstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nadia MattanahDepartment of Psychology, University of Maryland, College Park, MD, US 20740, USA.ORCID https://orcid.org/0009-0000-4484-502X
Aditi RingwalaDepartment of Psychiatry, University of Maryland Treatment Center, University of Maryland, Baltimore, MD, USA.
Atri SurapaneniDepartment of Psychiatry, University of Maryland, Baltimore, Baltimore, MD, USA.ORCID https://orcid.org/0009-0005-0247-4888
Kellie MillerDepartment of Psychiatry, University of Maryland, Baltimore, Baltimore, MD, USA.
Anne SawyerDepartment of Psychiatry, University of Maryland, Baltimore, Baltimore, MD, USA.
Shivakumar NarayananInstitute of Human Virology, Division of Clinical Care and Research, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-3440-0259

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Contingency management (CM) has been used to reinforce abstinence in the treatment of substance use disorders (SUD). Novel applications of CM in people who use drugs (PWUD) have been used to facilitate other desirable behaviors. Objective: Describe and assess preliminary outcomes of a program intended to reduce risk for HIV and related infections in a population of PWUD through increased healthcare engagement. Design: Patients receiving care for SUD at a collocated clinic receive shaping CM-based incentives for risk assessment, testing, and clinic attendance. Methods: Baseline cohort characteristics are assessed, and engagement in clinical care during the early period of the program is described. Results: Participants are majority African American, female, and meet criteria for experiencing financial resource strain. During the first year of the program, no significant changes in clinic appointment attendance were observed. Conclusion: Patient-centered CM-based incentivization implemented in a low-barrier, harm-reduction setting may facilitate incremental health behavior changes to reduce infection-related comorbid risk. There is a need to expand approaches to those with high risk and barriers.

Indexed as

contingency managementharm reductionHIVrisk behaviorsexually transmitted infectionssubstance use disorders

Identifiers

PMID41884791
PMCPMC13009620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.